Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81
Sex
Women only
Ages
Ages 18 Years to 50 Years
Primary completion
2024-04-30
Last update
2025-01-10

What this trial studies

The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young breast cancer survivors' engagement in goal-concordant oncofertility care, concurrently with observing and gathering information on how the intervention is implemented. The investigators hypothesize that implementation of the intervention will result in increased young breast cancer survivors' engagement in goal-concordant oncofertility care.

Conditions in scope

  • Breast Cancer
  • Fertility
  • Contraception
  • Menopausal Symptoms

Interventions

  • Multi-component oncofertility care intervention (Behavioral) — The intervention includes: 1. Young breast cancer patients presenting to oncology visits will complete a clinic-based oncofertility needs screen with a member of the clinical team. This needs screen assesses i) desire to have a child in the future, ii)…

Who can join

Women only · Ages 18 Years to 50 Years

Inclusion criteria

  • Breast cancer (Stages 0-IV) diagnosis
  • Primary language English or Spanish
  • Receiving oncology care at participating clinical sites
  • Living in Imperial County, California

Exclusion criteria

  • \- Women who are pregnant at recruitment

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Brawley California Pioneers Medical Health District Unknown
El Centro California Cancer Resource Center of the Desert Unknown
El Centro California El Centro Regional Medical Center Unknown
La Jolla California University of California San Diego Unknown

Status & timeline

  • Overall status: Completed
  • Study type: Interventional
  • Phase: N/A
  • Start date: 2021-10-15
  • Primary completion: 2024-04-30
  • Last update posted: 2025-01-10
  • First posted: 2022-06-10

Lead sponsor: University of California, San Diego (Other)

Collaborators: Cancer Resource Center of the Desert, El Centro Regional Medical Center, Pioneers Memorial Healthcare District

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • Medical record review of engagement in goal-concordant oncofertility care (12 weeks after oncology visit)
    Study staff will be trained to abstract the primary outcome of engagement in goal-concordant oncofertility care from the patient's medical records using standardized case report forms. Engagement in goal-concordant oncofertility care will be assigned to young breast cancer survivors who undergo: 1) oncofertility needs screen, complete a navigation session, receive the women's health survivorship care plan (SCP), and thereafter have…

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT05414812 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.